Your search for major depressive disorder returned 24 results

Researchers analyzed MRI-derived images of participants with mental illness to evaluate the heterogeneity of gray matter volume deviations.

Researchers conducted a phase 2 trial to assess the safety and efficacy of single-dose psilocybin treatment for major depressive disorder.

Researchers sought to assess the cognitive effects of PTSD in patients with drug-resistant epilepsy who have PTSD symptoms.

Researchers investigated the all-cause risk for mortality in patients with major depressive disorder exhibiting suicidal behavior.

Researchers sought to evaluate the safety of COVID-19 vaccination in pregnant and breastfeeding women with autoimmune diseases.

In a systematic review and meta-analysis, estimates for depressive disorders in children younger than 13 years old were evaluated.

A study sought to determine the prevalence of depression and cognitive dysfunction in patients receiving TAVR for aortic stenosis and its effect on mortality.

Researchers evaluated the magnitude, timing, and durability of antidepressant effects and safety of a single dose of psilocybin in patients with major depressive disorder.

Researchers examined the patient burden of tardive dyskinesia.

A study was conducted to determine the effect of mental health disorders on postoperative outcomes following EVAR in patients who are veterans.

Botulinum toxin injections can improve quality of life for patients across a variety of aspects of health care, including pain management, urology, dermatology, and more.

Researchers evaluated the risk for major depressive disorder among patients with HIV infection.

In a retrospective cohort study, researchers assessed the association between prurigo nodularis with sleep disorders.

Ulotaront is a trace amine-associated receptor 1 agonist with 5-HT1A agonist activity.

Researchers sought to assess the association between sleep-related adverse events and antidepressant dosage.

In a multicenter, observational, cohort study, researchers investigated the incidence dynamics and long-term neurologic outcome of neuro-COVID disorders.

Researchers examined long-term associations between COVID-19 infection and the risk of mortality and multiorgan complications among older adults.

Researchers aimed to assess the association between metformin and dementia risk and compare this with patients with type 2 diabetes who do not use antidiabetic drugs.

Researchers sought to assess how objective cognitive deficits in depression are associated with symptoms, neural circuits, and treatment outcomes.

Some men have said that honest communication and community-based approaches make them more like to engage in mental health care.

Researchers sought to assess the effectiveness and tolerability of vortioxetine in improving depressive symptoms, cognitive performance, functioning, and health-related quality of life in patients with depression and early dementia.

The US Preventive Services Task Force (USPSTF) recommends depression screening for all adults and anxiety screening for younger adults.

In response to patient concerns that use of unsanitized PAP equipment may cause respiratory infections, researchers assessed RIs in patients with OSA initiating PAP.

Researchers assessed whether clinical severity and instability, during a 2-month period, were predictors of later risk for psychiatric hospitalization within the next 6 months.